These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 8281697)
1. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. St John Sutton M; Pfeffer MA; Plappert T; Rouleau JL; Moyé LA; Dagenais GR; Lamas GA; Klein M; Sussex B; Goldman S Circulation; 1994 Jan; 89(1):68-75. PubMed ID: 8281697 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. St John Sutton M; Pfeffer MA; Moye L; Plappert T; Rouleau JL; Lamas G; Rouleau J; Parker JO; Arnold MO; Sussex B; Braunwald E Circulation; 1997 Nov; 96(10):3294-9. PubMed ID: 9396419 [TBL] [Abstract][Full Text] [Related]
3. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). van Gilst WH; Kingma JH; Peels KH; Dambrink JH; St John Sutton M J Am Coll Cardiol; 1996 Jul; 28(1):114-21. PubMed ID: 8752803 [TBL] [Abstract][Full Text] [Related]
4. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846 [TBL] [Abstract][Full Text] [Related]
5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. Pfeffer MA; Braunwald E; Moyé LA; Basta L; Brown EJ; Cuddy TE; Davis BR; Geltman EM; Goldman S; Flaker GC N Engl J Med; 1992 Sep; 327(10):669-77. PubMed ID: 1386652 [TBL] [Abstract][Full Text] [Related]
6. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Rutherford JD; Pfeffer MA; Moyé LA; Davis BR; Flaker GC; Kowey PR; Lamas GA; Miller HS; Packer M; Rouleau JL Circulation; 1994 Oct; 90(4):1731-8. PubMed ID: 7923656 [TBL] [Abstract][Full Text] [Related]
7. [Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies]. Pfeffer MA; Braunvald Iu; Moĭe LA; Basta L; Braun EDzh ; Kaddi TE; Dévis BR; Geltman EM; Goldman S; Fleĭker GS Kardiologiia; 1993; 33(12):14-23, 3. PubMed ID: 7910865 [TBL] [Abstract][Full Text] [Related]
8. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA; Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009 [TBL] [Abstract][Full Text] [Related]
9. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up. Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951 [TBL] [Abstract][Full Text] [Related]
10. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective. Pfeffer MA Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423 [TBL] [Abstract][Full Text] [Related]
11. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Lamas GA; Flaker GC; Mitchell G; Smith SC; Gersh BJ; Wun CC; Moyé L; Rouleau JL; Rutherford JD; Pfeffer MA Circulation; 1995 Sep; 92(5):1101-9. PubMed ID: 7648653 [TBL] [Abstract][Full Text] [Related]
12. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy. Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K; Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200 [TBL] [Abstract][Full Text] [Related]
13. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. Iliceto S; Scrutinio D; Bruzzi P; D'Ambrosio G; Boni L; Di Biase M; Biasco G; Hugenholtz PG; Rizzon P J Am Coll Cardiol; 1995 Aug; 26(2):380-7. PubMed ID: 7608438 [TBL] [Abstract][Full Text] [Related]
14. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. Rouleau JL; Packer M; Moyé L; de Champlain J; Bichet D; Klein M; Rouleau JR; Sussex B; Arnold JM; Sestier F J Am Coll Cardiol; 1994 Sep; 24(3):583-91. PubMed ID: 7915733 [TBL] [Abstract][Full Text] [Related]
16. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. Pinto YM; van Gilst WH; Kingma JH; Schunkert H J Am Coll Cardiol; 1995 Jun; 25(7):1622-6. PubMed ID: 7759715 [TBL] [Abstract][Full Text] [Related]
17. Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: comparison with digitalis. Bonaduce D; Petretta M; Arrichiello P; Conforti G; Montemurro MV; Attisano T; Bianchi V; Morgano G J Am Coll Cardiol; 1992 Mar; 19(4):858-63. PubMed ID: 1531993 [TBL] [Abstract][Full Text] [Related]
18. Quantitative echocardiography in left ventricular remodeling after myocardial infarction. Sutton MS Curr Opin Cardiol; 1996 Jul; 11(4):378-85. PubMed ID: 8879948 [TBL] [Abstract][Full Text] [Related]
19. Early treatment with captopril after acute myocardial infarction. Ray SG; Pye M; Oldroyd KG; Christie J; Connelly DT; Northridge DB; Ford I; Morton JJ; Dargie HJ; Cobbe SM Br Heart J; 1993 Mar; 69(3):215-22. PubMed ID: 8461219 [TBL] [Abstract][Full Text] [Related]
20. Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial). Kenchaiah S; Pfeffer MA; St John Sutton M; Plappert T; Rouleau JL; Lamas GA; Sasson Z; Parker JO; Geltman EM; Solomon SD Am J Cardiol; 2004 Jul; 94(1):1-8. PubMed ID: 15219499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]